World's Best Scientists 2026 revealed!
Brent A. Neuschwander-Tetri

Brent A. Neuschwander-Tetri

D-Index & Metrics

Medicine

D-Index
86
Citations
54376
World Ranking
13841
National Ranking
7025

Brent A. Neuschwander-Tetri publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Brent A. Neuschwander-Tetri sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 284 publications — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Brent A. Neuschwander-Tetri D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Brent A. Neuschwander-Tetri sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Brent A. Neuschwander-Tetri is affiliated with Saint Louis University in the United States and has a substantial body of work primarily within the field of Medicine. Their research focuses extensively on hepatology and related subfields.

The scientist's main fields of study include:

  • Medicine

Within Medicine, their subfields of study encompass:

  • Epidemiology
  • Hepatology
  • Endocrinology, Diabetes and Metabolism
  • Cell Biology
  • Surgery

The key topics of research addressed by Neuschwander-Tetri cover areas such as:

  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Liver Disease and Transplantation
  • Endoplasmic Reticulum Stress and Disease
  • Liver Diseases and Immunity
  • Pancreatitis Pathology and Treatment
  • Alcohol Consumption and Health Effects

Significant recent publications authored or coauthored by them include:

  • "MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease," 2020, Gastroenterology
  • "AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease," 2023, Hepatology
  • "Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease," 2021, New England Journal of Medicine
  • "Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease," 2023, Hepatology
  • "TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial," 2021, Gastroenterology

Neuschwander-Tetri frequently collaborates with several co-authors, with whom they have multiple joint publications. These include:

  • Rohit Loomba
  • Arun J. Sanyal
  • David E. Kleiner
  • Kris V. Kowdley
  • Danielle Carpenter

Their work appears in prominent journals with recurring publications in:

  • Journal of Hepatology
  • Hepatology
  • The American Journal of Gastroenterology
  • Gastroenterology
  • Hepatology Communications

Best Publications

  • Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

    Elizabeth M Brunt;Christine G Janney;Adrian M Di Bisceglie;Brent A Neuschwander-Tetri

  • Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

    Arun J. Sanyal;Naga Chalasani;Kris V. Kowdley;Arthur McCullough

  • Mechanisms of NAFLD development and therapeutic strategies

    Scott L. Friedman;Brent A. Neuschwander-Tetri;Mary Rinella;Arun J. Sanyal

  • Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

    Brent A. Neuschwander‐Tetri;Brent A. Neuschwander‐Tetri;Stephen H. Caldwell;Stephen H. Caldwell

  • MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.

    Mohammed Eslam;Arun J Sanyal;Jacob George

  • Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

    Brent A Neuschwander-Tetri;Rohit Loomba;Arun J Sanyal;Joel E Lavine

  • Nonalcoholic steatohepatitis: An expanded clinical entity

    Bruce R. Bacon;Mohammad J. Farahvash;Christine G. Janney;Brent A. Neuschwander-Tetri

  • Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites

    Brent A. Neuschwander‐Tetri

  • Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings

    Elizabeth M. Brunt;David E. Kleiner;Laura A. Wilson;Patricia Belt

  • Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

    Brent A. Neuschwander-Tetri;Elizabeth M. Brunt;Kent R. Wehmeier;Dana Oliver

  • Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

    Stephen Harrison;Dana Oliver;Hays L. Arnold;Sudhanshu Gogia

  • Humanized xenobiotic response in mice expressing nuclear receptor SXR.

    Wen Xie;Joyce L. Barwick;Michael Downes;Bruce Blumberg

  • Nonalcoholic fatty liver disease

    Elizabeth M. Brunt;Vincent W.-S. Wong;Valerio Nobili;Christopher P. Day

  • Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.

    Arun J. Sanyal;Mark L. van Natta;Jeanne Clark;Brent A. Neuschwander-Tetri

  • Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

    Stephen A. Harrison;Will Fecht;Elizabeth M. Brunt;Brent A. Neuschwander-Tetri

  • Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease.

    Kris V. Kowdley;Patricia Belt;Laura A. Wilson;Matthew M. Yeh

  • Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

    Stephen A Harrison;Stephen A Harrison;Mustafa R Bashir;Cynthia D Guy;Rong Zhou

  • Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

    Brent A. Neuschwander-Tetri;Jeanne M. Clark;Nathan M. Bass;Mark L. Van Natta

  • Severe NAFLD with hepatic necroinflammatory changes in mice fed trans-fats and a high fructose corn syrup equivalent

    Laura H. Tetri;Metin Basaranoglu;Elizabeth M. Brunt;Lisa M. Yerian

  • Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial.

    Arun Sanyal;Edgar D Charles;Brent A Neuschwander-Tetri;Rohit Loomba

Frequent Co-Authors

Rohit Loomba
Rohit Loomba University of California, San Diego
Elizabeth M. Brunt
Elizabeth M. Brunt Washington University in St. Louis
Arun J. Sanyal
Arun J. Sanyal Virginia Commonwealth University
David E. Kleiner
David E. Kleiner National Institutes of Health
Naga Chalasani
Naga Chalasani Indiana University
Kris V. Kowdley
Kris V. Kowdley Washington State University
James Tonascia
James Tonascia Johns Hopkins University
Joel E. Lavine
Joel E. Lavine Columbia University
Srinivasan Dasarathy
Srinivasan Dasarathy Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring alternatives or complementary routes to a traditional medical degree, there are diverse online healthcare programs to consider. For non-nursing majors interested in advanced nursing roles, online direct entry MSN programs for non-nursing majors provide a streamlined pathway to earn a master's in nursing without a previous nursing background.

Some aspiring healthcare professionals may prefer training programs with fewer admission hurdles. There are easy nursing programs to get into, making the journey toward becoming a nurse more accessible—even for those without a high GPA or standardized test scores.

Beyond hands-on care, the allied health field offers options like medical billing and coding. Many reputable colleges offer financial aid for medical billing and coding online classes so students can gain in-demand skills for administrative healthcare jobs.

For prospective Licensed Practical Nurses, there’s also the option to enroll in an lpn program without teas test requirements. This can be an ideal choice for those looking to start their nursing career quickly and with fewer entrance barriers.

Best Scientists Citing Brent A. Neuschwander-Tetri

Trending Scientists